Responses to dupilumab (Dupixent) treatment were consistent across racial and ethnic groups in children with atopic ...

Dupilumab in atopic dermatitis treatment had the most favorable cardiometabolic safety profile when compared with methotrexate and cyclosporine.

A study found that children with early-onset atopic dermatitis have a higher risk of developing uveitis and should be closely ...

Medically reviewed by Casey Gallagher, MD Atopic dermatitis (the most common type of eczema) causes dry, itchy skin with ...

Janus kinase (JAK) inhibitors, including ruxolitinib cream and abrocitinib, demonstrate strong efficacy in atopic dermatitis ...

Netherlands: A recent real-world, long-term study from the BioDay Registry has highlighted a significant incidence of ...

A cohort study finds children with early-onset atopic dermatitis to be at increased risk for uveitis, highlighting a need for ophthalmologic monitoring in youth.

Atopic dermatitis is an allergy affecting approximately 10% of the Japanese population, with symptoms closely related to ...

Children with severe AD had a significantly higher risk of developing pediatric uveitis compared to those with nonsevere AD ...

Dupixent approved as the first-ever biologic medicine in Japan for patients with COPDFollowing recent approvals in the EU, China, and the US, ...